Barriers and enablers of adherence to infant nevirapine prophylaxis against HIV 1 transmission among 6-week-old HIV exposed infants: A prospective cohort study in Northern Uganda.
Agnes NapyoThorkild TylleskärDavid MukunyaJosephine TumuhamyeMilton W MusabaAnna Agnes Ojok ArachPaul WaakoJames K TumwineGrace NdeeziPublished in: PloS one (2020)
Despite mothers receiving nevirapine syrup from the health workers for the infant, non-adherence rates still prevail at 14.8%. The health system needs to consider giving HIV infected pregnant women the nevirapine syrup before birth to avoid delays and non-adherence. There is need to pay particular attention to younger women and those who recently started ART.
Keyphrases
- hiv infected
- antiretroviral therapy
- pregnant women
- human immunodeficiency virus
- hiv positive
- hiv aids
- pregnancy outcomes
- healthcare
- public health
- hiv testing
- hepatitis c virus
- glycemic control
- mental health
- men who have sex with men
- working memory
- type diabetes
- health information
- skeletal muscle
- metabolic syndrome
- clinical trial
- health insurance
- weight loss
- social media